News

GO2 for Lung Cancer Holds Lung Cancer Voices Summit on Capitol Hill to Advocate for Increased Research Funding for the Leading Cause of Cancer Death

2024-03-04T10:21:55-06:00March 4th, 2024|Advocacy in Action, Hot Topics, News, Press Releases|

More than 230,000 Americans will die of lung cancer this year WASHINGTON, March 4, 2024 - On Tuesday, March 5 GO2 for Lung Cancer (GO2) will host more than 200 supporters on Capitol Hill to educate members of Congress on the [...]

FDA Approves Tepmetko (tepotinib) for People with Metastatic Non-Small Cell Lung Cancer with MET-Exon 14 Mutation

2024-02-26T16:07:12-06:00February 16th, 2024|Hot Topics, News|

On Feb. 15, 2024, the U.S. Food and Drug Administration (FDA) granted traditional approval of Tepmetko (tepotinib) for people living with metastatic non-small cell lung cancer (NSCLC) with a MET-Exon 14 mutation. Tepmetko (tepotinib) initially received accelerated approval in [...]

Lung Cancer is the Leading Cause of Cancer Death in Women—GO2 for Lung Cancer President & CEO Provides Testimony as Part of the “Legislative Proposals to Support Patients and Caregivers” Hearing

2024-02-21T09:11:24-06:00February 16th, 2024|Advocacy in Action, Hot Topics, News, Press Releases|

WASHINGTON, Feb. 16, 2023—GO2 for Lung Cancer President and CEO Laurie Ambrose submitted testimony to the House Committee on Energy and Commerce, Subcommittee on Health. Ambrose’s testimony was in support of the Women and Lung Cancer Research & Preventive [...]

GO2 for Lung Cancer Appoints Courtney Granville, Ph.D., M.S.P.H. as Chief Scientific Officer

2024-02-12T08:22:16-06:00February 12th, 2024|Hot Topics, News, Press Releases|

Granville brings experience overseeing scientific strategy and research  WASHINGTON, Feb. 12, 2024 — GO2 for Lung Cancer (GO2) announced that it has hired Courtney Granville as chief scientific officer. In this role, she oversees GO2’s community-engaged research, clinical research, Lung Cancer [...]

ASCO Issues New Recommendation Cosela (Trilaciclib) in Update to its Treatment Guidelines for Small Cell Lung Cancer

2023-10-20T12:24:54-05:00October 20th, 2023|Hot Topics, News, Science and Research, Small Cell Lung Cancer|

On October 11, 2023, the American Society of Clinical Oncology (ASCO) recommended an update to its treatment guidelines for small cell lung cancer (SCLC). Cosela (trilaciclib) has been recommended as a myeloid supportive agent for individuals with extensive-stage SCLC who [...]

Go to Top